GRI Bio
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $6,333 |
Gross Profit | -1 | -1 | -1 | -1 |
EBITDA | -1,648 | -2,002 | -2,663 | -3,364 |
EBIT | -2,003 | -2,003 | -2,664 | -3,365 |
Net Income | -1,643 | -1,998 | -2,659 | -3,359 |
Net Change In Cash | 0 | 0 | 0 | 6,333 |
Free Cash Flow | -1,446 | -3,685 | -2,974 | -2,313 |
Cash | 10,947 | 11,048 | 8,229 | 4,055 |
Basic Shares | 1,804 | 1,241 | 497 | 93 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $22,538 | $21,767 | $0 |
Gross Profit | -4 | -4 | -57 | -50 |
EBITDA | -11,973 | -8,231 | -10,951 | -2,561 |
EBIT | -11,977 | -8,235 | -10,955 | -2,564 |
Net Income | -11,956 | -8,207 | -13,037 | -3,217 |
Net Change In Cash | 0 | 22,538 | 21,767 | 0 |
Free Cash Flow | -10,189 | -8,611 | -8,998 | -1,088 |
Cash | 8,229 | 5,028 | 1,808 | 9 |
Basic Shares | 98 | 4,915 | 1 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.91 |
2026-03-31 | -$1.61 |
2025-12-31 | -$116.61 |
2025-09-30 | -$35.84 |